New guidelines for IPF and PPF

Home > Pulmonology > ATS 2022

American Thoracic Society
13–18 May 2022
San Francisco, CA, USA

New guidelines for IPF and PPF

Presented By

Dr Elisabeth Renzoni, Royal Brompton Hospital, UK

Conference

ATS 2022

19 May, 2022 12:37

No screening evidence for COPD

Presented By

Prof. Carol Mangione, University of California at Los Angeles, CA, USA

Conference

ATS 2022

18 May, 2022 12:04

Online First

New guidelines for IPF and PPF

Presented By

Dr Elisabeth Renzoni, Royal Brompton Hospital, UK

Conference

ATS 2022

19 May, 2022 12:37

Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?

Presented By

Prof. Ulrich Specks, Mayo Clinic, MN, USA

Trial

Phase 3, ADVOCATE

Conference

ATS 2022

19 May, 2022 12:35

Novel P2X3 antagonist can SOOTHE chronic cough

Presented By

Prof. Jaclyn Smith, University of Manchester, UK

Trial

Phase 2, SOOTHE

Conference

ATS 2022

19 May, 2022 12:34

PAGANINI phase 2b data promising for eliapixant

Presented By

Prof. Peter Dicpinigaitis, Albert Einstein College of Medicine, NY, USA

Trial

Phase 2, PAGANINI

Conference

ATS 2022

19 May, 2022 12:32

POISE-3: Tranexamic acid for non-cardiac surgery

Presented By

Prof. Philip Devereaux, McMaster University, Canada

Trial

Phase 3, POISE-3

Conference

ATS 2022

19 May, 2022 12:31

Colistimethate sodium PROMISing for non-cystic fibrosis bronchiectasis

Presented By

Dr Charles Haworth, Royal Papworth Hospital, UK

Trial

Phase 3, PROMIS

Conference

ATS 2022

19 May, 2022 12:29

Type 2 asthma managed by dupilumab, despite atopic comorbidities

Presented By

Prof. Theresa Guilbert, University of Cincinnati, OH, USA

Trial

Phase 3, Liberty Asthma VOYAGE

Conference

ATS 2022

18 May, 2022 12:06

NAVIGATOR steers asthma patients to tezepelumab

Presented By

Prof. Njira Lugogo, University of Michigan, MI, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2022

18 May, 2022 12:05

No screening evidence for COPD

Presented By

Prof. Carol Mangione, University of California at Los Angeles, CA, USA

Conference

ATS 2022

18 May, 2022 12:04

COVI-PRONE trial on its back

Presented By

Prof. Waleed Alhazzani, McMaster University, Canada

Trial

COVI-PRONE

Conference

ATS 2022

18 May, 2022 12:02

High-intensity interval training slashes daily corticosteroids in asthma

Presented By

Dr Anders Pitzner-Fabricius, Rigshospitalet Copenhagen, Denmark

Conference

ATS 2022

18 May, 2022 12:00

Obstructive sleep apnoea in most kids with PH

Presented By

Prof. Daniel Ignatiuk, Cincinnati Children’s Hospital, OH, USA

Conference

ATS 2022

18 May, 2022 11:59

Novel PDE4B inhibitor offers breakthrough for IPF

Presented By

Prof. Luca Richeldi, Università Cattolica del Sacro Cuore, Italy

Trial

Phase 2

Conference

ATS 2022

17 May, 2022 11:54

MANDALA patterns success for albuterol-budesonide in asthma

Presented By

Prof. Alberto Papi, University of Ferrara, Italy

Trial

Phase 3, MANDALA

Conference

ATS 2022

17 May, 2022 11:52

SPRINTER still in the running?

Presented By

Dr Phillip Monk, Synairgen Research LtD, UK

Trial

Phase 3, SPRINTER

Conference

ATS 2022

17 May, 2022 11:50

Lung transplantation after COVID-19-associated ARDS

Presented By

Prof. G.R. Scott Budinger, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Conference

ATS 2022

17 May, 2022 11:49

Hydrocortisone does not help pre-term infants

Presented By

Prof. Namasivayam Ambalavanan, University of Alabama, AL, USA

Conference

ATS 2022

17 May, 2022 11:48

CPAP supports pulmonary oxygenation in morbidly obese patients

Presented By

Dr Felix Girrbach, University Hospital of Leipzig, Germany

Conference

ATS 2022

17 May, 2022 11:46

Medical Conferences

ATS 2022

Featured articles

New guidelines for IPF and PPF

No screening evidence for COPD

CONTENTS

Online First

New guidelines for IPF and PPF

Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?

Novel P2X3 antagonist can SOOTHE chronic cough

PAGANINI phase 2b data promising for eliapixant

POISE-3: Tranexamic acid for non-cardiac surgery

Colistimethate sodium PROMISing for non-cystic fibrosis bronchiectasis

Type 2 asthma managed by dupilumab, despite atopic comorbidities

NAVIGATOR steers asthma patients to tezepelumab

No screening evidence for COPD

COVI-PRONE trial on its back

High-intensity interval training slashes daily corticosteroids in asthma

Obstructive sleep apnoea in most kids with PH

Novel PDE4B inhibitor offers breakthrough for IPF

MANDALA patterns success for albuterol-budesonide in asthma

SPRINTER still in the running?

Lung transplantation after COVID-19-associated ARDS

Hydrocortisone does not help pre-term infants

CPAP supports pulmonary oxygenation in morbidly obese patients